Mohler JL - Search Results

1

Phase II study of Dutasteride for recurrent prostate cancer during androgen deprivation therapy.

Shah SK, Trump DL, Sartor O, Tan W, Wilding GE, Mohler JL. Shah SK, et al. Among authors: mohler jl. J Urol. 2009 Feb;181(2):621-6. doi: 10.1016/j.juro.2008.10.014. Epub 2008 Dec 16. J Urol. 2009. PMID: 19091347 Free PMC article. Clinical Trial.

2

Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging.

McSherry SA, Levy F, Schiebler ML, Keefe B, Dent GA, Mohler JL. McSherry SA, et al. Among authors: mohler jl. J Urol. 1991 Jul;146(1):85-9. doi: 10.1016/s0022-5347(17)37720-0. J Urol. 1991. PMID: 1711590

3

A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis.

Partin AW, Walsh AC, Pitcock RV, Mohler JL, Epstein JI, Coffey DS. Partin AW, et al. Among authors: mohler jl. J Urol. 1989 Nov;142(5):1254-8. doi: 10.1016/s0022-5347(17)39049-3. J Urol. 1989. PMID: 2810502

4

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy.

Partin AW, Piantadosi S, Sanda MG, Epstein JI, Marshall FF, Mohler JL, Brendler CB, Walsh PC, Simons JW. Partin AW, et al. Among authors: mohler jl. Urology. 1995 May;45(5):831-8. doi: 10.1016/S0090-4295(99)80091-0. Urology. 1995. PMID: 7538245

5

Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue.

Miyamoto KK, McSherry SA, Dent GA, Sar M, Wilson EM, French FS, Sharief Y, Mohler JL. Miyamoto KK, et al. Among authors: mohler jl. J Urol. 1993 May;149(5):1015-9. doi: 10.1016/s0022-5347(17)36284-5. J Urol. 1993. PMID: 7683339

6

Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy.

Moul JW, Maygarden SJ, Ware JL, Mohler JL, Maher PD, Schenkman NS, Ho CK. Moul JW, et al. Among authors: mohler jl. J Urol. 1996 Mar;155(3):982-5. J Urol. 1996. PMID: 8583622 Clinical Trial.

7

Comparison of subcapsular and total orchiectomy for treatment of metastatic prostate cancer.

Zhang XZ, Donovan MP, Williams BT, Mohler JL. Zhang XZ, et al. Among authors: mohler jl. Urology. 1996 Mar;47(3):402-4. doi: 10.1016/S0090-4295(99)80460-9. Urology. 1996. PMID: 8633409 Clinical Trial.

8

Expectant management as an option for men with stage T1c prostate cancer: a preliminary study.

Mohler JL, Williams BT, Freeman JA. Mohler JL, et al. World J Urol. 1997;15(6):364-8. doi: 10.1007/BF01300184. World J Urol. 1997. PMID: 9436286

9

Evaluation of biomarker modulation by fenretinide in prostate cancer patients.

Urban D, Myers R, Manne U, Weiss H, Mohler J, Perkins D, Markiewicz M, Lieberman R, Kelloff G, Marshall M, Grizzle W. Urban D, et al. Eur Urol. 1999;35(5-6):429-38. doi: 10.1159/000019875. Eur Urol. 1999. PMID: 10325501 Clinical Trial.

10

Outcomes after radical retropubic prostatectomy.

Noh C, Kshirsagar A, Mohler JL. Noh C, et al. Among authors: mohler jl. Urology. 2003 Feb;61(2):412-6. doi: 10.1016/s0090-4295(02)02147-7. Urology. 2003. PMID: 12597958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters